DK2131813T3 - Topiske, farmaceutiske formuleringer - Google Patents

Topiske, farmaceutiske formuleringer

Info

Publication number
DK2131813T3
DK2131813T3 DK08709428.0T DK08709428T DK2131813T3 DK 2131813 T3 DK2131813 T3 DK 2131813T3 DK 08709428 T DK08709428 T DK 08709428T DK 2131813 T3 DK2131813 T3 DK 2131813T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical formulations
topical pharmaceutical
topical
formulations
pharmaceutical
Prior art date
Application number
DK08709428.0T
Other languages
Danish (da)
English (en)
Inventor
Adrian Francis Davis
Original Assignee
Futura Medical Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Futura Medical Dev Ltd filed Critical Futura Medical Dev Ltd
Application granted granted Critical
Publication of DK2131813T3 publication Critical patent/DK2131813T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK08709428.0T 2007-03-13 2008-02-15 Topiske, farmaceutiske formuleringer DK2131813T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0704846.5A GB0704846D0 (en) 2007-03-13 2007-03-13 Topical pharmaceutical formulation
PCT/GB2008/000540 WO2008110741A2 (en) 2007-03-13 2008-02-15 Topical pharmaceutical formulation

Publications (1)

Publication Number Publication Date
DK2131813T3 true DK2131813T3 (da) 2012-10-29

Family

ID=37988913

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08709428.0T DK2131813T3 (da) 2007-03-13 2008-02-15 Topiske, farmaceutiske formuleringer

Country Status (21)

Country Link
US (1) US8541470B2 (enExample)
EP (2) EP2452671A2 (enExample)
JP (1) JP2010521442A (enExample)
CN (1) CN101663022A (enExample)
AU (1) AU2008224735B2 (enExample)
BR (1) BRPI0808887A2 (enExample)
CA (1) CA2680074C (enExample)
CO (1) CO6220926A2 (enExample)
DK (1) DK2131813T3 (enExample)
ES (1) ES2391914T3 (enExample)
GB (1) GB0704846D0 (enExample)
MX (1) MX2009009758A (enExample)
MY (1) MY149545A (enExample)
NZ (1) NZ579895A (enExample)
PL (1) PL2131813T3 (enExample)
PT (1) PT2131813E (enExample)
RU (1) RU2468794C2 (enExample)
SG (1) SG179480A1 (enExample)
TW (1) TWI367110B (enExample)
UA (1) UA100509C2 (enExample)
WO (1) WO2008110741A2 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3300721B2 (en) * 2003-11-20 2025-01-08 Novo Nordisk A/S Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
SG10201703086VA (en) 2008-10-17 2017-05-30 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their use as therapeutic agents
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
JP5752136B2 (ja) 2009-10-14 2015-07-22 ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． スピロ−オキシインドール化合物のための合成方法
CN105726531A (zh) 2010-02-26 2016-07-06 泽农医药公司 用于局部给药的螺-羟吲哚化合物的药物组合物及其作为治疗剂的用途
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
AU2013246485A1 (en) 2012-04-12 2014-10-16 Xenon Pharmaceuticals Inc. Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
PL3795141T3 (pl) * 2013-01-14 2025-11-12 Infirst Healthcare Limited Kompozycje w postaci roztworu stałego
EP2943183A1 (en) * 2013-01-14 2015-11-18 InFirst Healthcare Limited Compositions and methods for treating severe pain
HK1218621A1 (zh) * 2013-02-04 2017-03-03 Infirst Healthcare Limited 用於治疗慢性炎症和炎性疾病的组合物及方法
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
TW201636017A (zh) 2015-02-05 2016-10-16 梯瓦製藥國際有限責任公司 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法
GB201502845D0 (en) * 2015-02-20 2015-04-08 Futura Medical Dev Ltd Topical pharmaceutical formulation
FR3041534B1 (fr) * 2015-09-30 2019-03-15 Vetoquinol Sa Composition de nettoyant auriculaire
GB201609968D0 (en) * 2016-06-07 2016-07-20 Futura Medical Dev Ltd Topical pharmaceutical formulation
US10100060B2 (en) 2016-06-16 2018-10-16 Xenon Pharmaceuticals Inc. Asymmetric synthesis of funapide
WO2018163176A1 (en) * 2017-03-07 2018-09-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Topical delivery systems for active compounds
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface
CN118903386A (zh) 2017-08-24 2024-11-08 诺和诺德股份有限公司 Glp-1组合物及其用途
KR20220143036A (ko) 2020-02-18 2022-10-24 노보 노르디스크 에이/에스 약학적 제형
GB2596286B (en) 2020-06-20 2023-01-25 Francis Davis Adrian Adherence to topical therapy
EP4188325A1 (en) 2020-07-27 2023-06-07 Incanthera R&D Ltd. Topical formulation
GB2597526A (en) 2020-07-27 2022-02-02 Incanthera R&D Ltd Topical formulation
GB202012836D0 (en) 2020-08-17 2020-09-30 Futura Medical Developments Ltd Topical composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06104624B2 (ja) * 1986-05-07 1994-12-21 太郎 小木曽 経皮吸収剤
PE20011092A1 (es) 2000-02-14 2001-11-12 Procter & Gamble Composiciones para el suministro topico de un agente farmaceuticamente activo que tiene reducida irritacion de la piel
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
PE20040321A1 (es) * 2002-08-22 2004-07-15 Novartis Consumer Health Sa Composicion topica que comprende diclofenaco
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
US20050137164A1 (en) * 2003-09-22 2005-06-23 Moshe Arkin Diclofenac compositions for the treatment of skin disorders
EP1588697A1 (en) 2004-04-16 2005-10-26 Kurt H. Prof. Dr. Bauer Emulsion gel for topical application of pharmaceuticals
US20050244522A1 (en) 2004-04-30 2005-11-03 Carrara Dario Norberto R Permeation enhancer comprising genus Curcuma or germacrone for transdermal and topical administration of active agents

Also Published As

Publication number Publication date
GB0704846D0 (en) 2007-04-18
WO2008110741A8 (en) 2009-11-19
PL2131813T3 (pl) 2012-11-30
NZ579895A (en) 2012-02-24
CA2680074A1 (en) 2008-09-18
TWI367110B (en) 2012-07-01
WO2008110741A2 (en) 2008-09-18
MX2009009758A (es) 2009-09-24
WO2008110741A3 (en) 2009-03-12
US20100099767A1 (en) 2010-04-22
RU2009136228A (ru) 2011-04-20
RU2468794C2 (ru) 2012-12-10
AU2008224735B2 (en) 2013-04-18
UA100509C2 (ru) 2013-01-10
AU2008224735A1 (en) 2008-09-18
EP2131813A2 (en) 2009-12-16
TW200836769A (en) 2008-09-16
JP2010521442A (ja) 2010-06-24
SG179480A1 (en) 2012-04-27
EP2131813B1 (en) 2012-08-08
CA2680074C (en) 2016-07-12
ES2391914T3 (es) 2012-12-03
MY149545A (en) 2013-09-13
PT2131813E (pt) 2012-10-31
CN101663022A (zh) 2010-03-03
EP2452671A2 (en) 2012-05-16
US8541470B2 (en) 2013-09-24
BRPI0808887A2 (pt) 2014-09-02
CO6220926A2 (es) 2010-11-19

Similar Documents

Publication Publication Date Title
DK2131813T3 (da) Topiske, farmaceutiske formuleringer
LTPA2018005I1 (lt) Farmacinė kompozicija
BRPI0820381A2 (pt) Formulações farmacêuticas
DK2139494T3 (da) Farmaceutiske formuleringer, der indeholder dapagliflozin-propylenglycolhydrat
NO20093032L (no) Topiske formuleringer med økt biotilgjengelighet
BRPI0721651A2 (pt) Composição farmacêutica
HUE041959T2 (hu) Kannabinoid-tartalmú extraktumok, mint neuroprotektív ágensek
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
HUE052378T2 (hu) Lokális topikális adagolású, indoxacarb tartalmú formulációk
BRPI0812354A2 (pt) Composição farmacêutica não-aquosa.
NO20075628L (no) Farmasøytiske formuleringer
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
BRPI0814188A2 (pt) Formulações
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
BRPI0921654A2 (pt) formulação farmacêutica
PT2209464E (pt) Composição farmacêutica antimalárica
BRPI0820198A2 (pt) composições farmacêuticas
DK2182988T3 (da) Radiofarmaceutisk præparat
EP2193795A4 (en) AQUEOUS PHARMACEUTICAL COMPOSITION CONTAINING LATANOPROST
BRPI0914182A2 (pt) composto, e, composição farmacêutica
BRPI0912656A2 (pt) formulação farmacêutica sólida
EP2156832A4 (en) PHARMACEUTICAL COMPOSITION